Detalhe da pesquisa
1.
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study.
PLoS Biol;
12(7): e1001906, 2014 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25003521
2.
Defining a standard set of patient-centred outcomes for lung cancer.
Eur Respir J;
48(3): 852-60, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27390281
3.
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer.
Clin Transl Radiat Oncol;
25: 61-66, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33072895
4.
Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study.
BMJ Open;
9(1): e019903, 2019 01 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30700475
5.
Clinical development of new drug-radiotherapy combinations.
Nat Rev Clin Oncol;
13(10): 627-42, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27245279